Final Programme - iuphar

Programme outline
Plenary lectures
Tue 17:30 IUL Paul M Vanhoutte The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old.
Sun 17:30 OL Jeffrey K Aronson Found in translation: Human pharmacology and applied
pharmacology come of age.
Mon 08:30 PL01 Salvador Moncada Vascular endothelium: Physiology, pharmacology and vascular
disease.
Mon 08:30 PL02 Klaus Cichutek Regulatory aspects of biomedicines.
Mon 08:30 PL03 Trevor Sharp Pharmacological control of central serotonin neurons.
Mon 17:30 PL04 Emmanuel Canet The challenges of the pharmaceutical industry in the 21st centure.
Mon 17:30 PL05 Stefanie Dimmeler Cell therapy.
Mon 17:30 PL06 Carlos Villalon The complex effects of 5-hydroxytryptamine in the cardiovascular
system.
Tue 08:30 PL07 Matthias Schwab Personalized medicine beyond pharmacogenetics.
Tue 08:30 PL08 Thomas Pogge The Health Impact Fund: Making new medicines more accessible
also for the poor
Tue 08:30 PL09 Barry Halliwell Antioxidants & free radicals, good or bad?
Wed 08:30 PL10 Brian K Kobilka Structural insights into GPCR activation.
Wed 08:30 PL11 Masamitsu Iino Calcium and cell functions.
Wed 08:30 PL12 Otto Cars Meeting the challenge of antibiotic resistance.
Wed 17:30 PL13 Jes Olesen New drug targets for headache.
Wed 17:30 PL14 Shizuo Akira Toll-like receptor and innate immunity.
Wed 17:30 PL15 Sue P Duckles Understanding the neuroprotective effect of estrogen; inflammation,
age and mitochondria.
Thu 08:30 PL16 Olavi Pelkonen Drug metabolism – past, present and future.
Thu 08:30 PL17 Morris J Brown Therapeutic potential of vaccines in the management of
hypertension.
Thu 08:30 PL18 Ian E Hughes Teaching pharmacology in 2020.
Thu 17:30 PL19 Peter J Barnes Reversal of corticosteroid resistance in severe inflammatory
diseases: A novel therapeutic strategy.
Thu 17:30 PL20 Ernesto Schiffrin Renin-angiotensin system and vascular inflammation.
Thu 17:30 PL21 Thomas Lönngren Successes and challenges in drug development – a regulatory
perspective.
Fri 08:30 PL22 Ding-Feng Su New strategies for stroke prevention.
Fri 08:30 PL23 Elisabeth Bock New molecular targets in Alzheimer’s disease.
Fri 08:30 PL24 Bernd Mayer Pharmacology of organic nitrates: From 19th century homeopathy
to genetic mouse models.
Focused conferences
FC01 Clinical pharmacology in the emerging countries
Mon 09:30 FC01.1 Clinical pharmacology and promotion of rational use of medicines in emerging and
developing countries
Mon 14:30 FC01.2 Clinical pharmacology and drug regulation in resource limited settings
Tue 09:30 FC01.3 Clinical trials in countries with developing and emerging economies
Tue 14:30 FC01.4 Pharmacovigilance in emerging and developing countries: A luxury or a must?
18 Programme outline